Physical Examination:
Level of consciousness: Awake/asleep? Can they be roused and stay awake?
Skin Color and appearance: Warm and pink vs. cyanotic? Cool, clammy? Diaphoretic?
Vital Signs: HR, BP, respirations, breath sounds, and SpO2 - are they normal?
Mental Status: AAO x 3 (Alert and Oriented to person, place, and time)?
Anxiety/Agitation: Determine if anxiety alone is the problem.
Patient History and Diagnosis:
PMH (Past Medical History) and diagnosis.
Pre-existing pulmonary or neuromuscular diseases.
Traumatic injuries to head or spine.
ARF (Acute Respiratory Failure): Respiratory activity is absent or insufficient for CO2 removal and O2 uptake.
Inability to maintain acceptable PaO2, PaCO2, and pH levels.
Criteria:
PaO2 < 70 on > 0.6 FiO2
PaCO2 > 55 and rising
pH < 7.25
Types of Respiratory Failure:
Hypoxic Respiratory Failure
Hypercapnic Respiratory Failure
May not require mechanical ventilation; O2 therapy and/or CPAP may suffice.
Causes: V/Q mismatch, diffusion defects
Inability to maintain normal PaCO2.
Causes: CNS, neuromuscular, and WOB (Work of Breathing) disorders.
Mild to moderate:
Respiratory findings: Tachypnea, Dyspnea
Cardiovascular findings: Paleness, Tachycardia, Mild hypertension, Peripheral vasoconstriction
Neurological findings: Restlessness, Disorientation, Headaches, Lassitude
Severe:
Respiratory findings: Tachypnea, Dyspnea
Cardiovascular findings: Cyanosis, Tachycardia and eventual bradycardia, arrhythmias, Hypertension and eventual hypotension
Neurological findings: Somnolence, Confusion, Blurred vision, Tunnel vision, Loss of coordination, Impaired judgment, Slow reaction time, Manic-depressive activity, Coma
Mild to moderate:
Respiratory findings: Tachypnea, Dyspnea
Cardiovascular findings: Tachycardia, Hypertension, Vasodilation
Neurological findings: Headaches, Drowsiness
Severe:
Respiratory findings: Tachypnea and eventual bradypnea
Cardiovascular findings: Tachycardia, Hypertension and eventual hypotension
Neurological findings: Hallucinations, Hypomania, Convulsions, Coma
Signs: Sweating, Redness of the skin.
Generally cause hypoventilation.
Causes:
Drugs: sedatives, narcotics, pain medications
Brain trauma or pathology: stroke, CHI, ICB, CVA – “Cheyne-Stokes or Biot’s” respirations
Pathology induced CO2 narcosis: PaCO2 > 70 mmHg acts as CNS depressant.
Paralytic disorders: M.G. (Myasthenia Gravis), G.B. (Guillain-Barré syndrome), Tetanus, M.S. (Multiple Sclerosis)
Paralytic Drugs: Succinylcholine, Norcuron, Pavulon, Zemuron, Curare, nerve gas
Other drugs affecting muscle function: certain antibiotics, long-term steroids
Impaired muscle function: electrolyte imbalances, malnutrition, air-trapping.
Pleural lesions: pneumo/hemothorax, effusions, empyema
Chest wall deformities: Trauma, obesity, kyphoscoliosis
Increased airway resistance: bronchospasm, mucosal edema, airway inflammation
Lung tissue pathology: ARDS, pulmonary edema
MIP (Maximum Inspiratory Pressure) or NIF (Negative Inspiratory Force):
Maximum negative pressure a patient can generate during an inspiratory effort.
Requires significant patient effort.
Indicates ability to take a deep breath.
VC (Vital Capacity):
Maximum inspiration followed by maximum expiration.
Indicates ability to generate a significant cough.
NIF and VC can be performed every 2-4 hours.
PEFR (Peak Expiratory Flow Rate):
Indicates ability to maintain adequate airway patency.
Routinely measured pre and post bronchodilator therapy during Asthma exacerbation.
RR (Respiratory Rate): Normal range is 12 – 20 breaths/min.
MV (Minute Ventilation): Normal range is 5 – 6 L/min.
Criteria | Normal Range | Critical Value* |
---|---|---|
Ventilatory mechanics | ||
MIP (cm H₂O) | -50 to -100 | 0 to -20 |
MEP (cm H₂O) | +100 | <+40 |
VC (mL/kg) | 65-75 | <15 |
Tidal volume (Vt) (mL/kg) | 5-8 | <5 |
Respiratory frequency (f) (breaths/min) | 12-20 | >35 |
FEV₁ (mL/kg) | 50-60 | <10 |
Ventilation | ||
pH | 7.35-7.45 | <7.25 |
PaCO2 (mm Hg) | 35-45 | >55 and rising |
VD/VT | 0.3-0.4 | >0.6 |
Oxygenation+ | ||
PaO2 (mm Hg) | 80-100 | <70 (on O₂) |
P(A-a)O2 (mm Hg) | 3-30 | >450 (on O₂) |
PaO2/FiO2 | 475 | <200 |
Indicates need for mechanical ventilatory support.
Indicates need for oxygen therapy or PEEP/CPAP.
PaCO2 is the best indicator of adequate ventilation.
Increased Dead Space: VD/VT ratio 0.3 – 0.4.
Dead space is an area that is ventilated but not perfused.
Pathological example: pulmonary embolus.
PaO2 is the best indicator of adequate oxygenation.
SpO2 is an acceptable non-invasive alternative (except with abnormal hemoglobin types).
CaO2 is a good indicator of a patient’s total oxygen carrying capacity.
CaO2 = (Hb \times 1.34 \times SaO2) + (PaO2 \times 0.003), normal = 19.5 vol.%
Oxygen Therapy, Hi-Flo O2 therapy.
Hi-Flow nebulizer, Heated or unheated.
NPPV (Non-invasive Positive Pressure Ventilation)
Physiological objectives
To support or manipulate pulmonary gas exchange:
Alveolar ventilation-normal or deliberate hyperventilation (sustained hypocapnia)
Alveolar oxygenation-maintain oxygen delivery (CaO2 x cardiac output) at or near normal
Increase lung volume:
Prevent or treat atelectasis with adequate end-inspiratory lung inflation
Achieve and maintain an adequate functional residual capacity (FRC)
Reduce the work of breathing
Clinical objectives
Reverse acute respiratory failure
Reverse respiratory distress
Reverse hypoxemia
Prevent or reverse atelectasis
Reverse ventilatory muscle fatigue
Permit sedation and/or paralysis
Reduce systemic or myocardial oxygen consumption
Reduce intracranial pressure
Stabilize the chest wall
Apnea or absence of breathing/airway protection
Acute Respiratory Failure
Impending Respiratory Failure
Refractory hypoxic Respiratory Failure with increased WOB.
Acute exacerbation of COPD with complicating factors.
Does the patient have a “DNR” (Do Not Resuscitate) or “DNI” (Do Not Intubate) status?
Does the patient have an “Advanced Directive?”